MedinCell receives a new grant to develop a best-in-class long-acting injectable product for HIV PrEP
5 September 2019
Our news
Bringing you the latest!
Investors
MedinCell partners to address the untapped financial potential in Animal Health
28 August 2019
LAI antipsychotic using MedinCell’s technology receives FDA IND clearance to initiate clinical activities
26 August 2019
MedinCell receives 7,5 M€ from the European Bank of Investment (EIB)
23 July 2019
Publication of the activity report and financial information for the first half-year (April – Sept. 2018)
3 December 2018
Publication of the activity report and financial information for the first half-year on December 3, 2018
27 November 2018